Figure 2.

E3Ab inhibits ovarian cancer growth in vivo. Caov-3 subcutaneous xenografts mouse models were established and E3Ab, lidocaine, or PBS were intratumoral administrated one week after inoculation (ten mice per group). (A) Tumor growth curves show E3Ab and lidocaine slowed down the growth of xenografts compared with the PBS group; (B) the xenografts in the E3Ab group and the lidocaine group were smaller than those from the PBS group; (C) HE staining of the xenografts. *, P<0.05 vs. control. E3Ab, third extracellular region antibody.